(Q34685727)

3 August 2017

title

Enhanced levels of interleukin-8 are associated with hepatitis B virus infection and resistance to interferon-alpha therapy (English)

1 reference

3 August 2017

1 reference

Kai Yang

1

1 reference

3 August 2017

Shi-He Guan

2

1 reference

3 August 2017

Hao Zhang

3

1 reference

3 August 2017

Ying Pan

4

1 reference

3 August 2017

Yuan-Yuan Wu

5

1 reference

3 August 2017

Ai-Hua Wang

6

1 reference

3 August 2017

Bei-Bei Sun

7

1 reference

3 August 2017

language of work or name

English

0 references

publication date

17 November 2014

1 reference

International Journal of Molecular Sciences

3 August 2017

published in

1 reference

3 August 2017

volume

15

1 reference

3 August 2017

issue

11

1 reference

3 August 2017

page(s)

21286-21298

1 reference

Creative Commons Attribution 4.0 International

3 August 2017

copyright license

start time

17 November 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

Aberrantly activated EGFR contributes to enhanced IL-8 expression in COPD airways epithelial cells via regulation of nuclear FoxO3A.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

Hepatitis B virus polymerase impairs interferon-α-induced STA T activation through inhibition of importin-α5 and protein kinase C-δ.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

Hepatitis B virus induces a novel inflammation network involving three inflammatory factors, IL-29, IL-8, and cyclooxygenase-2.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

Interferon-alpha induces high expression of APOBEC3G and STAT-1 in vitro and in vivo

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

MIQE précis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

Detection of serum TNF-alpha,IFN-beta,IL-6 and IL-8 in patients with hepatitis B.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4264225

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

7 July 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS151121286

Reduction of cirrhosis and hepatocellular carcinoma with antiviral therapy in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS151121286

Long-term effect of interferon therapy in patients with HBeAg positive chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS151121286

Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS151121286

Liver interleukin-8 messenger RNA expression and interferon sensitivity-determining region mutations relate to treatment response in hepatitis C 1b.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS151121286

An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS151121286

Prediction of the response to peg-interferon-alfa in patients with HBeAg positive chronic hepatitis B using decline of HBV DNA during treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS151121286

Efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis B: A multicenter clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS151121286

Increased plasma interleukin-8 concentrations in alcoholic hepatitis

21 January 2018

1 reference

12 December 2020

Intrahepatic interleukin-8 production during disease progression of chronic hepatitis C

1 reference

12 December 2020

Clinical significance of intrahepatic interleukin-8 in chronic hepatitis C patients

1 reference

12 December 2020

Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B

1 reference

12 December 2020

Serum IL-8 levels and localization of IL-8 in liver from patients with chronic viral hepatitis

1 reference

12 December 2020

Identifiers

DOI

10.3390/IJMS151121286

1 reference

3 August 2017

1 reference

3 August 2017

1 reference